Huang, Yi-ChenYi-ChenHuangChen, Yen-NienYen-NienChenChung, An-KoAn-KoChungChen, Yu-AnYu-AnChenPEI-LUNG CHENShen, Tang-LongTang-LongShenChen, Chien-YuChien-YuChenChiu, Han-MoHan-MoChiu2026-01-052026-01-052025-08-0615423565https://scholars.lib.ntu.edu.tw/handle/123456789/735040Background & aims: Germline genetic factors influence the clinical features of colorectal cancer (CRC); however, these factors remain underexplored in Taiwan. This study aims to evaluate the pathogenicity of germline variants and investigate their associations with familial risk and early-onset CRC. Methods: Whole exome sequencing of 600 Taiwanese patients with CRC was analyzed, assessing variant pathogenicity using American College of Medical Genetics and Genomics (ACMG) guidelines. Comparative analysis with 1492 controls identified candidate genes, and clinical features were correlated with genetic variants. Results: We identified several novel candidate genes, including CCDC18 and CEP135. A total of 24 pathogenic variants in hereditary cancer genes were found in 5.2% of Taiwanese patients with CRC, with the highest prevalence observed in early-onset cases (8.2%). Notably, a novel stop-gain variant in POLD1 (p.Y594X) was detected in a 26-year-old patient, suggesting dysfunction of the polymerase catalytic domain. The risks associated with ATM (1.3%) and the MUTYH (c.850-2A>G) variant were also highlighted. Additionally, 25.5% of rare-risk variants were novel, with 41 candidate pathogenic variants linked to familial and early-onset CRC. Conclusion: These findings improve our understanding of germline genetics in Taiwanese CRC, support better screening and management strategies, and highlight the need to expand Asian variant databases for improved risk assessment and care.entrueGermline GeneticHereditary Colorectal CancerPathogenic VariantWhole-exome Sequencingjournal article10.1016/j.cgh.2025.07.040407804022-s2.0-105025544089